Maarten J Deenen

11PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsNoise and wave pollution processes and measurementMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|Oct 02, 2025
Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction.

Helle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën

|Sep 09, 2025
Influence of ultrafiltration conditions on the unbound fraction of phenytoin and valproic acid.

Pjotr P Temme, Matthijs van Luin, Maarten J Deenen

|Jun 06, 2025
Precision Treatment of Patients With GI Cancer Using Pre-emptive DPYD Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-Fluorouracil.

Helle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën

|May 27, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.

Nikki de Rouw, Leila-Sophie Otten, Mart P Kicken

|Nov 23, 2024
Genetic association analysis and frequency of NUDT15*3 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort.

Maarten J Deenen, Anouk J van Noordenburg, Joëlle Bouwens-Bijsterveld

Pageof 2

Frequent Collaborators

2 joint publications

Pierre M Bet

2 joint publications

Jan Gerard Maring

2 joint publications

Dirk Jan A R Moes

2 joint publications

Richard M Brohet